Skip to main content
Clinical Trials/NCT03652025
NCT03652025
Unknown
N/A

The Effectiveness of Trans-catheter Foam Sclerotherapy of Pelvic and Atypical Lower Limb Varicosities

Assiut University0 sites20 target enrollmentOctober 15, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Venous Insufficiency
Sponsor
Assiut University
Enrollment
20
Primary Endpoint
The difference in pain score before and after therapy
Last Updated
7 years ago

Overview

Brief Summary

pelvic congestion is the most recognized consequence of pelvi-perineal venous insufficiency .

chronic pelvic pain prevalence is about 26.6 %in egypt. this research is going to evaluate the effectiveness of foam sclerotherapy and to conclude diagnostic and therapeutic algorithm for this problem.

Detailed Description

this study includes clinical and imaging and interventional aspects. detailed history and comprehensive examination of the patient. duplex ultrasonography to detect pelvic varices and presence of reflux. renal and left iliac venogram is usually the first step in the evaluation of compressive syndrome. then cannulate the gonadal and internal iliac veins selectively. contrast medium injected , the incompetent gonadal veins are generally dilated and the contrast pools in the pelvis after injection. embolization by injecting afoam sclerosant as distally as possible to occlude the pelvic venous plexus using occlusion balloon proximal. follow up assessment by VAS score and duplex imaging.

Registry
clinicaltrials.gov
Start Date
October 15, 2018
End Date
June 15, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

ahmadnaserhussein

principal investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • premenopausal women ovarian point tenderness post coital pain atypical lower limb varices

Exclusion Criteria

  • endometriosis diverticulitis fasciitis psychosexual dysfunction

Outcomes

Primary Outcomes

The difference in pain score before and after therapy

Time Frame: one year

validated analogue scoring of pain From 0 to 10 according to symptoms improvement

Similar Trials